Less Ads, More Data, More Tools Register for FREE

Belgium's UCB to buy US-based Ra Pharmaceuticals for $2.1bn

Thu, 10th Oct 2019 10:29

(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.
Under the terms of the deal, Ra Pharma shareholders will receive $48 per share in cash, which is a premium of about 93% to the Ra closing price prior to signing.

The transaction has been unanimously approved by the boards of directors of both companies but remains subject to approval by Ra Pharma shareholders, obtaining anti-trust clearance and other customary closing conditions.

The deal is expected to complete by the end of the first quarter of next year.

UCB's chief executive officer, Jean-Christophe Tellier, said: "Ra Pharma is an excellent strategic fit addressing multiple areas of UCB's patient value growth strategy. Upon closing, the acquisition will add to our strong internal growth opportunities - six potential product launches in the next five years, strengthening our neurology and immunology franchises with late and early-stage pipeline projects.

"In addition, the combination will provide us with the opportunity to become a leader in treating people living with myasthenia gravis, an auto-antibody mediated neurological orphan disease with high unmet medical need, as well as adding a highly productive technology platform to our innovation engine."

More News

UPDATE 2-New Swiss A220 jet engine failure forces checks

(Recasts, adds details of incident, industry background, changes dateline previously PARIS/VIENNA)By Tim Hepher and John RevillPARIS/ZURICH, Oct 15 (Reuters) - U.S. engine maker Pratt & Whitney faces new checks on engines for small jetliners after ...

Today 21:54

US STOCKS-Wall Street gains as earnings season begins in earnest

(For a live blog on the U.S. stock market, click LIVE/ or type LIVE/ in a news window.)* JPMorgan touches record high on earnings beat* UnitedHealth, Johnson & Johnson shares jump after results* Brexit hopes boost sentiment* Indexes up: Dow 0.89%, S...

Today 21:20

DUP says more work needed on PM Johnson's Brexit plan, gaps remain

LONDON, Oct 15 (Reuters) - The small Northern Irish party supporting Britain's minority government said further work was required on Prime Minister Boris Johnson's Brexit deal because gaps remain over what they can sign up to.Johnson is trying to ...

Today 21:06

US STOCKS SNAPSHOT-Upbeat earnings reports boost Wall Street

NEW YORK, Oct 15 (Reuters) - Wall Street advanced on Tuesday as the third-quarter earnings season hit the ground running with a spate of upbeat reports that brought buyers back to the equities market.The Dow Jones Industrial Average rose 237.64 po...

Today 21:02

Login to your account

Don't have an account? Click here to register.